KYMERA THERAPEUTICS INC's ticker is KYMR and the CUSIP is 501575104. A total of 129 filers reported holding KYMERA THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.11 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $263,572 | -37.3% | 18,962 | +3.7% | 0.00% | -33.3% |
| Q2 2023 | $420,441 | -22.2% | 18,288 | +0.2% | 0.00% | -25.0% |
| Q1 2023 | $540,718 | +21.1% | 18,249 | +2.0% | 0.00% | +33.3% |
| Q4 2022 | $446,435 | +14.2% | 17,886 | -0.4% | 0.00% | 0.0% |
| Q3 2022 | $391,000 | +12.4% | 17,951 | +1.4% | 0.00% | +50.0% |
| Q2 2022 | $348,000 | -51.8% | 17,698 | +3.7% | 0.00% | -50.0% |
| Q1 2022 | $722,000 | -37.7% | 17,060 | -6.6% | 0.00% | -33.3% |
| Q4 2021 | $1,159,000 | +4.9% | 18,261 | -2.9% | 0.01% | 0.0% |
| Q3 2021 | $1,105,000 | +40.6% | 18,807 | +16.1% | 0.01% | +100.0% |
| Q2 2021 | $786,000 | +244.7% | 16,198 | +175.6% | 0.00% | +200.0% |
| Q1 2021 | $228,000 | -37.2% | 5,877 | +0.3% | 0.00% | 0.0% |
| Q4 2020 | $363,000 | – | 5,861 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Life Science Advisors, LLC | 5,984,736 | $149,379,011 | 17.99% |
| Aquilo Capital Management, LLC | 629,411 | $15,710,099 | 5.90% |
| BVF INC/IL | 4,692,604 | $117,127,396 | 4.94% |
| Artal Group S.A. | 2,000,000 | $49,920 | 2.79% |
| Redmile Group, LLC | 2,673,837 | $66,738,972 | 2.73% |
| Avoro Capital Advisors LLC | 3,850,000 | $96,096,000 | 1.44% |
| Deer Management Co. LLC | 615,895 | $15,372,739 | 1.42% |
| AtonRa Partners | 27,125 | $677,040 | 0.86% |
| Rock Springs Capital Management LP | 1,227,779 | $30,645,364 | 0.74% |
| EcoR1 Capital, LLC | 796,093 | $19,870,481 | 0.60% |